Clinical trial · Observational
Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer
NCT02375035CI-TRIAL-00016959CAMPROBEunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the use of the CAMbridge PROstate Biopsy devicE (CAMPROBE) as a method of undertaking prostate biopsy as part of their clinical management.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Biopsy | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CAMPROBE | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Pain score assessment of CAMPROBE biopsy procedure
- timeFrame
- 3 weeks
- description
- Measured using a 10 point visual pain score tool and a point based structured questionnaire
- measure
- Patient reported adverse events related to CAMPROBE biopsy
- timeFrame
- 3 weeks
- description
- Point based structured questionnaire assessment of adverse events after biopsy
- measure
- Patient perception and acceptance of CAMPROBE biopsy
- timeFrame
- 3 weeks
- description
- Point based structured questionnaire including willingness to recommend to a friend
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Fit and well enough to undergo a repeat prostate biopsy * Men who have previously had a transrectal ultrasound biopsy of the prostate and due to have a repeat biopsy as part of normal care * Men on active surveillance * Men on PSA monitoring Exclusion Criteria: * Contraindication for a repeat prostate biopsy * Contraindication for a transperineal prostate biopsies * Previous perineal or anal surgery * MRI suggesting anterior lesion or extra capsular disease * MRI suggesting lesion that needs fusion image targeting * Unable to lie down and with legs in a stirrup for at least 45 minutes
References
Publications (0)
Data not yet available
No reference posted for this study.